$REGN and $ABBV - very similar dynamics Largo

Regeneron Pharmaceuticals, Inc.NASDAQ

Descripción

⋅ 11 de Dic. de 2020 7:36

This seems to me more than just coincidence considering the profile of product pipelines and therapeutic areas both companies bet on.

I was watching both for some time and placed a position to ABBV before earnings @ major support level, which was broken and then turned.

Major support @ 468 (50% monthly Fib level)
Potential upside to 700 with test of ATH 664.

Very good R/R of 1:7.

Good fundamentals on top of above made REGN a definitive buy for me as I was waiting a good price to enter.

Discussion purpose only, not an advice.

Comentarios

UI00

⋅ 8 de Ene. de 2021 22:54

Exactly what I thought after seeing REGN's spike today.

solidBus76050

⋅ 11 de Dic. de 2020 9:09

I agree, but support is not exactly 468, it can be easyly 450)

game_trader

⋅ 11 de Dic. de 2020 9:51

@solidBus76050, could be the case. I play my worse case scenario at 422, which still 1:3 R/R.
I believe now it's good time to start building the position.

Más